Mark M. Menning
13Patents
5h-index
14Co-inventors
59Inventor score
Filing activity: Jun 13, 2006 → Jan 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8592397B2 | Compositions and methods for combination antiviral therapy | Human Necessities | 29 | Active |
| US8716264B2 | Compositions and methods for combination antiviral therapy | Human Necessities | 29 | Active |
| US8598185B2 | Unitary pharmaceutical dosage form | Human Necessities | 8 | Active |
| US9018192B2 | Unitary pharmaceutical dosage form | Human Necessities | 7 | Active |
| US9457036B2 | Compositions and methods for combination antiviral therapy | Human Necessities | 5 | Active |
| US9545414B2 | Unitary pharmaceutical dosage form | Human Necessities | 5 | Active |
| US8871271B2 | Method and composition for pharmaceutical product | Human Necessities | 3 | Active |
| US11260047B2 | Formulations of AG10 | Human Necessities | 2 | Active |
| US9744181B2 | Compositions and methods for combination antiviral therapy | Human Necessities | 0 | Active |
| US10857102B2 | Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate | Human Necessities | 0 | Active |
| US10039718B2 | Use of solid carrier particles to improve the processability of a pharmaceutical agent | Human Necessities | 0 | Active |
| US12005043B2 | Formulations of AG10 | Human Necessities | 0 | Active |
| US9688666B2 | Lamivudine salts | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.